Ah, [000 00 00;00] ah. Hello and welcome to cross stock were all things are considered on peter labelle. Kevin, its western backers got some truly bad news. Last week, Amnesty International says ukraines fighting tactics endanger civilians, zalinski and his gang are not the innocent victims media claim. Plus, we hear a lot about a big offensive soon. Well, will it be ukrainian, or russian . Ah, hes got these issues bad more. Im joined by my guess, jordan some you only in budapest, hes a podcast or at the guy which can be found on youtube and locals. And here in moscow, we have to meet 3, bob and shes a political analyst and editor. And you know, its me, internet media project or gentleman cross top rules. And that means you can jump anytime you want. And i always appreciate it, right . Start out as me can government was very disappointed with the International Reports and claiming that the, the be grading, are you using violating the rules of law of war and, and could be potentially be
Replay Launches First 'Spoke' Companies - San Diego Business Journal sdbj.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sdbj.com Daily Mail and Mail on Sunday newspapers.
Telaria is developing a gene therapy for the rare skin disorder recessive dystrophic epidermolysis bullosa. The company was formed by Replay, a gene therapy biotech that forms subsidiaries that leverage its platform technologies for writing and delivering genetic medicines.